Not a Lexis+ subscriber? Try it out for free.
LexisNexis® CLE On-Demand features premium content from partners like American Law Institute Continuing Legal Education and Pozner & Dodd. Choose from a broad listing of topics suited for law firms, corporate legal departments, and government entities. Individual courses and subscriptions available.
WASHINGTON, D.C. - (Mealey's) The U.S. Supreme Court has denied tobacco companies' appeal of a Louisiana state court order to fund a $241 million medical monitoring and smoking cessation program, according to a clerk of the court report issued June 27 (Philip Morris USA Inc., et al. v. Deania M. Jackson, et al., No. 10-735, U.S. Sup.).
Tobacco defendants Phillip Morris USA Inc., the Tobacco Institute Inc., Lorillard Tobacco Co., R.J. Reynolds Tobacco Co. and Brown & Williamson Tobacco were ordered to fund the two programs by the Orleans Parish District Court after a trial.
The Fourth Circuit Louisiana Court of Appeal issued an opinion in April 2010 affirming the order but recalculated the amount of the judgment for the plaintiffs from $591.6 million to $241 million plus interest (No. 09-461).
The companies filed an application for a stay and petition for a writ of certiorari.
Justice Antonin Scalia stayed the execution of the judgment in an order entered Sept. 14, pending the disposition of the petition for a writ of certiorari.
Deania M. Jackson and Gloria Scott are the plaintiffs representing the class in the appeal.
The petition for a writ of certiorari was considered at the June 23 conference of the justices.
[Editor's Note: Full coverage will be in the July issue of Mealey's Litigation Report: Tobacco. For all of your legal news needs, please visit www.lexisnexis.com/mealeys.]
For more information, call editor Michael Lefkowitz at 215-988-7732, or email him at michael.lefkowitz@lexisnexis.com.
Lexis.com subscribers may search all Mealey Publications.
Non-subscribers may search for Mealey Publications stories and documents at www.mealeysonline.com or visit www.Mealeys.com.
For more information about LexisNexis products and solutions, connect with us through our corporate site.